ArticleBJGP open2020
GPs' understanding of the benefits and harms of treatments for long-term conditions: an online survey.
Article in BJGP open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Trial
- Impact of the MHRA safety update on vitamin BBMC primary care · 2025Article
- Article
- People, humility, and ambition: our vision for the future of general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023Article
- The Impact of Web-Based Continuing Medical Education Using Patient Simulation on Real-World Treatment Selection in Type 2 Diabetes: Retrospective Case-Control Analysis.JMIR medical education · 2023Article
- Observational
- Using contextual factors to elicit placebo and nocebo effects: An online survey of healthcare providers' practice.PloS one · 2023Observational
- GPs' use and understanding of the benefits and harms of treatments for long-term conditions: a qualitative interview study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021Article
- Clinician Conceptualization of the Benefits of Treatments for Individual Patients.JAMA network open · 2021Article
- Shared decision making in consultations for hypertension: Qualitative study in general practice.Health expectations : an international journal of public participation in health care and health policy · 2021Article
- What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications.Therapeutic advances in psychopharmacology · 2021Review
- Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.Cardiovascular diabetology · 2020Article
- Rethinking screening during and after COVID-19: Should things ever be the same again?Canadian family physician Medecin de famille canadien · 2020Article
- How accurate are GPs at integrating evidence into prescribing decisions?The British journal of general practice : the journal of the Royal College of General Practitioners · 2020Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
backgroundGPs prescribe multiple long-term treatments to their patients. For shared clinical decision-making, understanding of the absolute benefits and harms of individual treatments is needed. International evidence shows that doctors' knowledge of treatment effects is poor but, to the authors knowledge, this has not been researched among GPs in the UK.
aimTo measure the level and range of the quantitative understanding of the benefits and harms of treatments for common long-term conditions (LTCs) among GPs. DESIGN &
settingAn online cross-sectional survey was distributed to GPs in the UK.
methodParticipants were asked to estimate the percentage absolute risk reduction or increase conferred by 13 interventions across 10 LTCs on 17 important outcomes. Responses were collated and presented in a novel graphic format to allow detailed visualisation of the findings. Descriptive statistical analysis was performed.
resultsA total of 443 responders were included in the analysis. Most demonstrated poor (and in some cases very poor) knowledge of the absolute benefits and harms of treatments. Overall, an average of 10.9% of responses were correct allowing for ±1% margin in absolute risk estimates and 23.3% allowing a ±3% margin. Eighty-seven point seven per cent of responses overestimated and 8.9% of responses underestimated treatment effects. There was no tendency to differentially overestimate benefits and underestimate harms. Sixty-four point eight per cent of GPs self-reported 'low' to 'very low' confidence in their knowledge.
conclusionGPs' knowledge of the absolute benefits and harms of treatments is poor, with inaccuracies of a magnitude likely to meaningfully affect clinical decision-making and impede conversations with patients regarding treatment choices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.